Psoriasis affects 100M globally—new study reveals hidden health dangers

Over 100 million people globally now live with psoriasis, according to new figures released by the International Federation of Psoriasis Associations (IFPA) and the WHO Foundation. The condition, which causes painful, scaly skin patches, remains poorly understood despite its widespread impact. A collaboration announced on February 10, 2026, aims to raise awareness of its far-reaching health consequences.

Psoriasis develops when the immune system triggers excessive inflammation, forcing skin cells to multiply too quickly. Beyond its visible effects, the disease can disrupt how the body processes insulin, increasing the risk of type 2 diabetes. Severe cases also raise the likelihood of certain cancers and heighten cancer-related mortality rates.

The condition's impact extends to mental health, with sufferers 1.5 times more likely to face depression and anxiety. Rates of schizophrenia and suicidal thoughts are also elevated among those affected. Around 30% of patients develop psoriatic arthritis, a painful joint complication.

Up to half of people with psoriasis also live with metabolic syndrome, a cluster of conditions that raise heart health risk. The more severe the psoriasis, the greater the chances of developing this syndrome. Untreated psoriasis can worsen over time, further increasing risks for cardiovascular disease, chronic kidney disease, and end-stage renal failure.

The disease's systemic inflammation links it to multiple serious health problems, from heart disease to kidney failure. Without proper management, psoriasis can lead to worsening symptoms and additional complications. The IFPA and WHO Foundation's partnership highlights the urgent need for better understanding and treatment of this complex condition.